TABLE 1.

Effects of G-CSF treatment on clinical outcome and brain damagea

Group (n)Median % (no. with adverse outcome/total no.) with:Median brain damage score (interquartile range)
Terminal illnessMotor sequelae
Control (32)34.4 (11/32)*19.0 (4/21)1.53 (0 to 5.22)**
G-CSF pretreatment (34)11.8 (4/34)*3.3 (1/30)0 (0 to 1.05)**
G-CSF late treatment (16)37.5 (6/16)10.0 (1/10)1.58 (0 to 8.55)
  • a Asterisks indicate statistically significant differences. *, P = 0.039, **, P = 0.008.